Advancements in Tumor Immunology Visualization
Researchers are employing new visualization tools to enhance the understanding of immune system behavior within tumors. These tools enable the detailed observation of cellular components and their interactions in tissue samples.
Historical Context of Tissue Analysis
For nearly 150 years, tissue samples have been analyzed using hematoxylin and eosin (H&E) staining, which reveals individual cells and structures for cancer diagnosis. In the 1940s, immunohistochemistry introduced the ability to detect specific proteins using blue and brown stains. Later, immunofluorescence allowed for the identification of specific antigens with fluorescent colors. These techniques provided insights into a limited number of cancer-related markers, such as estrogen and progesterone receptors in breast cancer, which have been valuable for guiding patient treatment.
However, these traditional methods, even with the addition of "omics" techniques like bulk and single-cell sequencing, lacked the ability to precisely locate markers within the tumor or fully elucidate cell-to-cell communication. For example, while sequencing could indicate T cells with killer capabilities, it did not confirm their presence within the tumor or their direct interaction with cancer cells.
Emergence of Spatial Profiling Technologies
Approximately five years ago, spatial proteomics emerged as a new technology. This technique generates images that reveal the location of distinct proteins, including those indicative of cancer-killing capabilities, within every cell on a slide simultaneously. This is achieved by applying antibodies tethered to protein-specific fluorescent substances, allowing their signals to be captured by a fluorescence microscope. Serial application and washing of these probes enable the mapping of numerous known proteins on a single slide.
Complementing this, spatial transcriptomics, a more recent technology, identifies the RNA present in each cell on a slide. This provides information on gene expression patterns, detailing cell types and their functions within the tumor microenvironment. These spatial technologies provide a comprehensive view of the immune system's spatial dynamics within tumors.
Research Findings and Implications
Researchers at Dana-Farber Cancer Institute are utilizing these tools to investigate cancer mechanisms.
-
Triple-Negative Breast Cancer: Investigator Judith Agudo's lab studied triple-negative breast cancer, a form of the disease that often resists chemotherapy and immunotherapy. Early spatial profiling studies in mouse models revealed that T cells were not uniformly distributed within tumors. Densely clustered T cells were observed in some areas, while other regions lacked active T cells. Further analysis identified quiescent (dormant) cancer cells in these T-cell-devoid regions. These quiescent cells were found to evade both immunotherapy and chemotherapy, indicating a potential mechanism for disease relapse. This finding suggests opportunities for developing new strategies to target these resistant cells, possibly through existing drugs in combination with current therapies, though this research remains in preclinical stages.
-
Glioblastoma Response to Treatment: Kai Wucherpfennig and David Reardon's teams have applied spatial profiling to analyze glioblastoma samples from patients in clinical trials, both before and after treatment with immunotherapy, with or without radiation. Glioblastoma is a brain cancer with a poor prognosis. The aim was to validate the mechanisms of action of these treatments within the tumor microenvironment.
- Radiation therapy has been shown to induce immune responses in some cancers, and laboratory experiments indicate that combining it with immune checkpoint inhibitors can enhance anti-cancer immunity.
- Reardon's team observed significant changes in the immune microenvironment in a subset of patients. Prior to treatment, T cells were scarce and localized near blood vessels. Following treatment, their numbers increased, and they penetrated deeper into the tumor tissue. These observations provide insight into how treatments alter the tumor microenvironment and immune cell activity at a spatial level previously unattainable.